Melexis NV (STU:MEX)
€ 82.7 -0.9 (-1.08%) Market Cap: 3.37 Bil Enterprise Value: 3.51 Bil PE Ratio: 15.96 PB Ratio: 5.60 GF Score: 97/100

Q2 2019 Melexis NV Earnings Call Transcript

Jul 31, 2019 / 03:00PM GMT
Release Date Price: €62.65 (+1.38%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to today's Melexis Quarter 2 2019 Results Conference Call. (Operator Instructions) I must advise you that this conference is being recorded today, Wednesday, 31st of July 2019.

And right now, I would now like to hand the conference over to your first speaker today, Ms. Françoise Chombar. Please go ahead, ma'am.

FranÃ;oise Chombar
Melexis NV - CEO, MD & Director

§ -

Thank you. Dear audience, welcome to the Melexis earnings call for the second quarter of 2019. As usual, I will comment on the business environment. And in the absence of our CFO today, who is out for a planned medical treatment, Geert Reynders, who is our Investor Relations, will then shed some light over the financial perspective. And of course, we will be happy to answer your questions afterwards.

Melexis' sales for the second quarter of 2019 came out in the middle of the guidance provided in April and has shade better than in the first quarter. The percentage split per region is now more in line

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot